|
1
|
Ziai JM and Siddon AJ: Education Committee
of the Academy of Clinical Laboratory Physicians and Scientists:
Pathology consultation on gene mutations in acute myeloid leukemia.
Am J Clin Pathol. 144:539–554. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Estey EH: Acute myeloid leukemia: 2013
update on risk-stratification and management. Am J Hematol.
88:318–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Estey E and Döhner H: Acute myeloid
leukaemia. Lancet. 368:1894–1907. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Medinger M, Lengerke C and Passweg J:
Novel prognostic and therapeutic mutations in acute myeloid
leukemia. Cancer Genomics Proteomics. 13:317–329. 2016.PubMed/NCBI
|
|
5
|
Chiu CF, Weng JR, Jadhav A, Wu CY,
Sargeant AM and Bai LY: T315 decreases acute myeloid leukemia cell
viability through a combination of apoptosis induction and
autophagic cell death. Int J Mol Sci. 17:pii: E1337. 2016.
View Article : Google Scholar
|
|
6
|
Liu X, Liao W, Peng H, Luo X, Luo Z, Jiang
H and Xu L: miR-181a promotes G1/S transition and cell
proliferation in pediatric acute myeloid leukemia by targeting ATM.
J Cancer Res Clin Oncol. 142:77–87. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Estey EH: Acute myeloid leukemia: 2014
update on risk-stratification and management. Am J Hematol.
89:1063–1081. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alemdehy MF and Erkeland SJ: MicroRNAs:
Key players of normal and malignant myelopoiesis. Curr Opin
Hematol. 19:261–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: Contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagai H, Hasegawa S, Uchida F, Terabe T,
Kanno Ishibashi N, Kato K, Yamagata K, Sakai S, Kawashiri S, Sato
H, et al: MicroRNA-205-5p suppresses the invasiveness of oral
squamous cell carcinoma by inhibiting TIMP-2 expression. Int J
Oncol. 52:841–850. 2018.PubMed/NCBI
|
|
14
|
Du B, Wu D, Yang X, Wang T, Shi X, Lv Y,
Zhou Z, Liu Q and Zhang W: The expression and significance of
microRNA in different stages of colorectal cancer. Medicine
(Baltimore). 97:e96352018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo Q, Luan J, Li N, Zhang Z, Zhu X, Zhao
L, Wei R, Sun L, Shi Y, Yin X, et al: MicroRNA-181 as a prognostic
biomarker for survival in acute myeloid leukemia: A meta-analysis.
Oncotarget. 8:89130–89141. 2017.PubMed/NCBI
|
|
16
|
Liu L, Ren W and Chen K: MiR-34a promotes
apoptosis and inhibits autophagy by targeting HMGB1 in acute
myeloid leukemia cells. Cell Physiol Biochem. 41:1981–1992. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao Y, Deng T, Su C and Shang Z: MicroRNA
217 inhibits cell proliferation and enhances chemosensitivity to
doxorubicin in acute myeloid leukemia by targeting KRAS. Oncol
Lett. 13:4986–4994. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wallace JA and O'Connell RM: MicroRNAs and
acute myeloid leukemia: Therapeutic implications and emerging
concepts. Blood. 130:1290–1301. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Zhao W, Bao P, Li C, Ma XQ, Li Y and
Chen LA: miR-339-5p inhibits cell migration and invasion in vitro
and may be associated with the tumor-node-metastasis staging and
lymph node metastasis of non-small cell lung cancer. Oncol Lett.
8:719–725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YL, Chen CM, Wang XM and Wang L:
Effects of miR-339-5p on invasion and prognosis of hepatocellular
carcinoma. Clin Res Hepatol Gastroenterol. 40:51–56. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shan W, Li J, Bai Y and Lu X: miR-339-5p
inhibits migration and invasion in ovarian cancer cell lines by
targeting NACC1 and BCL6. Tumour Biol. 37:5203–5211. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou C, Lu Y and Li X: miR-339-3p inhibits
proliferation and metastasis of colorectal cancer. Oncol Lett.
10:2842–2848. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barrera-Ramirez J, Lavoie JR, Maganti HB,
Stanford WL, Ito C, Sabloff M, Brand M, Rosu-Myles M, Le Y and
Allan DS: Micro-RNA profiling of exosomes from marrow-derived
mesenchymal stromal cells in patients with acute myeloid leukemia:
Implications in leukemogenesis. Stem Cell Rev. 13:817–825. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu JW, Hsieh MS, Hou HA, Chen CY, Tien HF
and Lin LI: Overexpression of SOX4 correlates with poor prognosis
of acute myeloid leukemia and is leukemogenic in zebrafish. Blood
Cancer J. 7:e5932017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fung TK, Leung AY and So CW: Sox4you: A
new player in C/EBPα leukemia. Cancer Cell. 24:557–559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fernando TR, Contreras JR, Zampini M,
Rodriguez-Malave NI, Alberti MO, Anguiano J, Tran TM, Palanichamy
JK, Gajeton J, Ung NM, et al: The lncRNA CASC15 regulates SOX4
expression in RUNX1-rearranged acute leukemia. Mol Cancer.
16:1262017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Alberich-Jorda M, Amabile G, Yang
H, Staber PB, Di Ruscio A, Welner RS, Ebralidze A, Zhang J,
Levantini E, et al: Sox4 is a key oncogenic target in C/EBPα mutant
acute myeloid leukemia. Cancer Cell. 24:575–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gabra MM and Salmena L: microRNAs and
acute myeloid leukemia chemoresistance: A mechanistic overview.
Front Oncol. 7:2552017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Chen H, Bai J and He A: MicroRNA:
An important regulator in acute myeloid leukemia. Cell Biol Int.
41:936–945. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yeh CH, Moles R and Nicot C: Clinical
significance of microRNAs in chronic and acute human leukemia. Mol
Cancer. 15:372016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mosakhani N, Missiry ME, Vakkila E,
Knuutila S and Vakkila J: Low expression of miR-18a as a
characteristic of pediatric acute lymphoblastic leukemia. J Pediatr
Hematol Oncol. 39:585–588. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen B, Zhang Y, Yu S, Yuan Y, Zhong Y, Lu
J and Feng J: MicroRNA-339, an epigenetic modulating target is
involved in human gastric carcinogenesis through targeting NOVA1.
FEBS Lett. 589:3205–3211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu ZS, Wu Q, Wang CQ, Wang XN, Wang Y,
Zhao JJ, Mao SS, Zhang GH, Zhang N and Xu XC: MiR-339-5p inhibits
breast cancer cell migration and invasion in vitro and may be a
potential biomarker for breast cancer prognosis. BMC Cancer.
10:5422010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren H, Zhang Y and Zhu H: MiR-339
depresses cell proliferation via directly targeting S-phase
kinase-associated protein 2 mRNA in lung cancer. Thorac Cancer.
9:408–414. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng
L, Chen F, Peng F and Li X: MiR-339-5p regulates the growth, colony
formation and metastasis of colorectal cancer cells by targeting
PRL-1. PLoS One. 8:e631422013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi S, Cao X, Gu M, You B, Shan Y and You
Y: Upregulated expression of SOX4 is associated with tumor growth
and metastasis in nasopharyngeal carcinoma. Dis Markers.
2015:6581412015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fang CL, Hseu YC, Lin YF, Hung ST, Tai C,
Uen YH and Lin KY: Clinical and prognostic association of
transcription factor SOX4 in gastric cancer. PLoS One.
7:e528042012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zheng JH, Jian ZX, Jin HS, Chen SC and
Wang GY: Expression of SOX4 gene and early recurrence of
hepatocellular carcinoma: Their relationship and the clinical
significance. Nan Fang Yi Ke Da Xue Xue Bao. 30:818–819. 2010.(In
Chinese). PubMed/NCBI
|
|
40
|
Wang B, Li Y, Tan F and Xiao Z: Increased
expression of SOX4 is associated with colorectal cancer
progression. Tumour Biol. 37:9131–9137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bao ZQ, Zhang CC, Xiao YZ, Zhou JS, Tao YS
and Chai DM: Over-expression of Sox4 and β-catenin is associated
with a less favorable prognosis of osteosarcoma. J Huazhong Univ
Sci Technolog Med Sci. 36:193–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun R, Jiang B, Qi H, Zhang X, Yang J,
Duan J, Li Y and Li G: SOX4 contributes to the progression of
cervical cancer and the resistance to the chemotherapeutic drug
through ABCG2. Cell Death Dis. 6:e19902015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Aaboe M, Birkenkamp-Demtroder K, Wiuf C,
Sørensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjøt L and
Ørntoft T: SOX4 expression in bladder carcinoma: Clinical aspects
and in vitro functional characterization. Cancer Res. 66:3434–3442.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zou J and Xu Y: MicroRNA-140 inhibits cell
proliferation in gastric cancer cell line HGC-27 by suppressing
SOX4. Med Sci Monit. 22:2243–2252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cheng Q, Wu J, Zhang Y, Liu X, Xu N, Zuo F
and Xu J: SOX4 promotes melanoma cell migration and invasion though
the activation of the NF-κB signaling pathway. Int J Mol Med.
40:447–453. 2017. View Article : Google Scholar : PubMed/NCBI
|
